The efficacy, safety and tolerability of the short 12-month MDR-TB regimen in Ukraine at the expense of using intravenous administration of anti-tuberculosis drugs during intensive phase

Conclusions: Administration of intravenous ATDs at the 1st month of treatment, using linezolid for short 12-month regimen of chemotherapy allows improve the outcomes in patients with MDR-TB and save total cost of treatment.

Source: European Respiratory Journal - December 6, 2017 Category: Respiratory Medicine Authors: Lytvynenko, N., Gumenuk, M., Varytska, H., Chobotar, O., Grankina, N. Tags: Tuberculosis Source Type: research